Complete Freund's adjuvant promotes the increases of IFN-γ and nitric oxide in suppressing chronic arthritis induced by pristane

Inflammation

Volumn 27, Issue 4, 2003, Pages 247-255

  Zheng, Cong Long ^a,b   Ohki, Kazunori ^a   Aslam Hossain, Md ^a   Kukita, Akiko ^a   Satoh, Toshimi ^a   Kohashi, Osamu ^a  

^a SAGA UNIVERSITY   (Japan)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Arthritis inhibition; Complete freund's adjuvant; Cytokines; Nitric oxide

Indexed keywords

CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE; PRISTANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC ARTHRITIS; COLORIMETRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOPHARMACOLOGY; INFLAMMATORY CELL; INGUINAL LYMPH NODE; NONHUMAN; RAT; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, EXPERIMENTAL; FREUND'S ADJUVANT; INTERFERON TYPE II; NITRIC OXIDE; RATS; RATS, INBRED LEW; TERPENES; UP-REGULATION;

ANIMALIA; CELL FUSING AGENT VIRUS;

EID: 0041883584     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025092615584     Document Type: Article

References (38)

1. Brooks, P. 1993. Clinical management of rheumatoid arthritis. Lancet 341:286-290.
2. Bresnihan, B., J. M. Alvaro-Gracia, M. Cobby, M. Doherty, Z. Domljan, P. Emery, et al. 1998. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41:2196-2204.
3. Elliott, M., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Biji, et al. 1994. Repeated therapy with monoclonal antibody to tumor necrosis factor-α (cA2) in patients with rheumatoid arthritis. Lancet 344:1125-1127.
4. Van Roon, J. A., F. P. Lafeber, and J. W. Bijlsma. 2001. Synergistic activity of intefieukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 44:3-12.
5. Cobelens, P. M., C. J. Heijnen, E. E. Nieuwenhuis, P. P. Kramer, R. van der Zee, W. van Eden, et al. 2000. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp 65 during disease. Arthritis Rheum. 43:2694-2702.
6. Muto, Y., J. Satoh, G. Muto, T. Msuda, M. Sagara, M. Fukuzawa, et al. 1997. Effect of long-term treatment with complete Freund's adjuvant on kk-ay mouse, a model of non-dependent diabetes mellitus. Clin. Immunol. Immunopathol. 83:53-59.
7. Shehadeh, N., F. Calcinaro, B. J. Bradley, I. Bruchlim, and K. J. Lafferty. 1994. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707.
8. Kahn, G., M. G. Buzzi, U. Sabatini, E. Giugni, S. Bastianello, F. Viselli, et al. 1999. Use of bacilli calmette-guerin (BCG) in multiple sclerosis. Neurology 53:1588-1589.
9. Kahn, D., D. C. Archer, D. P. Gold, and C. J. Kelly. 2001. Adjuvant immunotherapy is dependent on inducible nitric oxide synthase. J. Exp. Med. 193:1261-1267.
10. Balagon, M. V., D. S. Walsh, P. L. Tan, R. V. Cellona, R. M. Abalos, E. V. Tan, et al. 2000. Improvement in psoriasis after intradermal administration of heat-killed mycobacterium vaccae. Int. Dermatol. 39:51-58.
11. Wooley, P., S. Sud, J. D. Whalen, and S. Nasser. 1998. Pristane-induced arthritis in mice. Arthritis Rheum. 41:2022-2031.
12. Vingsbo, C., P. Sahlstrand, J. G. Brun, R. Jonsson, T. Saxne, and R. Halmdahl. 1996. Pristane-induced arthritis in rats: A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149:1675-1683.
13. Wooley, P., J. R. Seibold, J. D. Whalen, and J. M. Chapdelaine. 1989. Pristane-induced arthritis: The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 32:1022-1030.
14. +T cell dependent. Immunology 90:81-86.
15. Trentham, D. E., A. S. Townes, and A. H. Kang. 1997. Autoimmunity to type II collagen: An experiment model of arthritis. J. Exp. Med. 146:857-868.
16. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat human glyceraldehydes-3-phosphate dehydrogenase cDNA: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2486-2502.
17. Schmidt-Weber, C. B., D. Pohlers, A. Siegling, H. Schadlich, E. Buchner, H. D. Volk, et al. 1999. Cytokine gene activation in synovial membrane regional lymph nodes, spleen during the course of rat adjuvant arthritis. Cell Immunol. 195:53-65.
18. Zipris, T., D. L. Greiner, S. Malkani, B. Whalen, J. P. Mordes, and A. A. Rossini. 1999. Cytokine gene expression in islets and thyroids of BB rats. J. Immunol. 156:1315-1321.
19. Zhang, H., T. Morisaki, H. Matsunaga, N. Sato, A. Uchiyama, K. Hashizume, et al. 2000. Protein-bound polysaccharide PKS inhibits tumor invasiveness by down-regulation of TGF-b and MMPs. Clin. Exp. Metastasis 18:343-352.
20. Trembleau, S., T. Germann, M. K. Gately, and L. Adorini. 1995. The role of IL-2 in the induction of organ-specific autoimmune disease. Immunol. Today 16:383-386.
21. Cooper, S. M., S. Sriram, and G. E. Ranges. 1988. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J. Immunol. 141:1958-1962.
22. Williams, R. O., D. G. Williams, M. Feldmann, and R. N. Maini. 1993. Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin. Exp. Immumol. 92:323-327.
23. Manoury-Schwartz, B., G. Chiocchia, N. Bessis, O. Abehsira-Amar, F. Batteux, S. Muller, et al. 1997. High susceptibity to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol. 158:5501-5506.
24. Wiesenberg, I., P. H. Van der Meide, H. Schellebens, and S. S. Alkan. 1989. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin. Exp. Immunol. 78:245-249.
25. Fox, S. W. and T. J. Chambers. 2000. Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis. Biochem. Biophys. Res. Commun. 276:868-872.
26. Takayanayi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408:600-605.
27. Alvaro-Gracia, J. M., N. J. Zvaifler, and G. S. Firestein. 1990. Cytokines in chronic inflammatory arthritis. V: Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86:1790-1798.
28. Guedez, Y. B., K. B. Whittington, J. L. Clayton, L. B. Joosten, F. J. Van de Loo, W. B. van den Berg, and E. F. Rosloniec. 2001. Genedtic ablation of interferon-γ up-regulates interleukin-1β expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44:2413-2424.
29. Sicher, S C., M. A. Vazques, and C. Y. Lu. 1994. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1293-1300.
30. Tavares-Murta, B. M., J. S. Machado, S. H. Ferreira, and F. Q. Cunha. 2001. Nitric oxide mediates the inhibition of neutrophil migration induced by systemic administration of LPS. Inflammation 25:247-253.
31. De Caterina, R. P., P. Libby, H. B. Ping, V. J. Thannickal, T. B. Rajavsahisth, M. A. Gimbrone, et al. 1995. Nitric oxide decreased cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68.
32. Sandi, C., and C. Gauza. 1995. Evidence for nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur. J. Pharmacol. 274:17-23.
33. Arnett, A. A., R. P. Hellendall, G. K. Matsushima, K. Suzuki, V. E. Laubach, P. Sherman, et al. 2002. The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J. Immunol. 168:427-433.
34. Veihelmann, A., J. Landes, A. Hofbauer, M. Dorger, H. J. Refior, K. Messmer, et al. 2001. Exacerbation of antigen-induced arthritis in inducible nitric oxide synthase-deficient mice. Arthritis Rheum. 44:1420-1427.
35. Billigham, M. E. 1995. Mechanism and models in rheumatoid arthritis. ISBN 0-12-340440-1384-409.
36. Tsukano, M., Y. Nawa, and M. Kotani. 1983. Characterization of low dose induced suppressor cells in adjuvant arthritis in rats. Clin. Exp. Immunol. 53:60-66.
37. Qin, H. Y, M. W. Sadelain, C. Hitchon, J. Lauzon, and B. Shigh. 1993. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:2072-2080.
38. Zheng, C. L., M. A. Hossiain, A. Kukita, K. Ohki, T, Satoh, and O. Kohashi. 2002. Complete Freund's adjuvant suppresses the development and progression of pristane-induced arthritis in rats. Clin Immunol 103:204-209.